Timothy B. Curry, M.D., Ph.D., is a Professor of Anesthesiology and Assistant Professor of Physiology at Mayo Clinic, Rochester, Minnesota. He holds academic roles including Vice Chair for Clinical Practice in the Department of Anesthesiology and Perioperative Medicine, and leads initiatives in individualized medicine through the Center for Individualized Medicine. His research focuses on autonomic nervous system regulation of cardiovascular and metabolic functions, employing advanced techniques such as microneurography and glucose clamping. Key interests include perioperative outcomes, environmental physiology, and hyperbaric medicine. Education: B.A. in Molecular Biology & Biochemistry (Middlebury College) M.D./Ph.D. via Medical Scientist Training Program (SUNY Buffalo) Residency in Anesthesiology (Mayo Clinic) Research Interests: Dr. Curry’s work spans autonomic nervous system physiology, metabolic syndrome mechanisms, and perioperative glycemic control. He leads the Human Integrative Physiology and Clinical Pharmacology Laboratory and collaborates globally on microneurography studies. Recent projects include investigating cerebral oxygen metabolism under hypoxia and developing genomic medicine training programs (COGENT). Awards: Emerald Award for Excellence (2015) Mayo Excellence in Leadership Award (2009) Multiple research and teaching accolades Grants & Leadership: Co-director of Mayo’s Clinomics Program, Team Leader for Perioperative Glucose Management, and Chair of multiple committees overseeing clinical practice and research. Labs & Teams: Directs the Human Integrative Physiology Lab and collaborates with the Clinical Research Unit. Active in multidisciplinary teams addressing autonomic dysfunction and precision medicine.
Aonghus Lawlor is an Assistant Professor/Lecturer in Computer Science at the School of Computer Science, University College Dublin. His roles include coordinating modules such as Software Engineering, Data Structures, Machine Learning, and Final Year Project Foundations. He holds an Orcid identifier: 0000-0002-6160-4639. His research focuses on machine learning applications in medical imaging (e.g., MRI, CT), sports science, and healthcare systems. Notable areas include AI-driven diagnostics, cybersecurity in radiology, and genomics for agricultural optimization. Recent work explores ChatGPT4-vision in MS progression, knee osteoarthritis grading via anomaly detection, and reinforcement learning in exercise prescriptions. Professional activities include committee roles in ACM Recommender Systems and Intelligent User Interfaces, grant assessments, and peer reviewing. He has published 137+ outputs, emphasizing interdisciplinary AI solutions with clinical and agricultural impact. Teaching responsibilities span foundational CS courses to advanced ML and project modules. No formal awards are listed, but his work demonstrates contributions to AI ethics, health informatics, and agricultural genomics.
Olga G. Troyanskaya is a Professor of Computer Science and the Lewis-Sigler Institute for Integrative Genomics at Princeton University. She serves as Deputy Director for Genomics at the Simons Center for Data Analysis, Simons Foundation, NYC. Her research focuses on computational biology, integrating diverse high-throughput genomic datasets to model molecular pathways in health and disease. Professor of Computer Science and Lewis-Sigler Institute for Integrative Genomics Deputy Director for Genomics, Simons Center for Data Analysis Research Interests: Troyanskaya’s work addresses challenges in bioinformatics, including algorithm development for gene expression analysis, regulatory network modeling, and disease mechanism interpretation. She combines computational methods with experimental validation using S. cerevisiae as a model organism. Scientific Trends: Recent publications emphasize single-cell multiomics, deep learning for transcriptional regulation, cancer immunotherapy design, and epigenomic analysis of immune responses. Key themes include computational modeling of genetic networks, disease-specific pathway analysis, and high-resolution omics frameworks. Collaborative roles in autism, Alzheimer’s, kidney disease, and cancer research Developed tools like HumanBase for data-driven predictions
Dr. Kathryn Kaiser is an Assistant Professor in the Department of Health Behavior at the University of Alabama at Birmingham (UAB) School of Public Health. She holds concurrent appointments in multiple research centers including the Center for Clinical and Translational Science and the Nutrition Obesity Research Center (NORC). Her research focuses on meta-research methodologies, race/sex disparities in obesity, systematic reviews of nutrition interventions, and advancing FAIR data principles for scientific communication. Education: B.S. Microbiology (Texas A&M), B.S. Medical Technology (University of Texas Health Science Center), Ph.D. in Health Psychology (University of North Texas Health Science Center). Postdoctoral training in Vascular Biology/Hypertension at UAB. Extensive background in medical diagnostics instrumentation and laboratory science prior to academia. Research Interests: Systematic review methodologies, FAIR data standards, obesity disparities with a focus on neuroendocrine mechanisms, and translational research in bariatric surgery outcomes. Specializes in methodological rigor for clinical trials and evidence synthesis. Grants: NIH-funded projects on FAIR principles implementation, dairy intake research, obesity energetics, and lifespan studies. Recent grants include $2.1M for metadata education programs and $1.8M for knowledge mapping initiatives. Awards: Recognized as 2015 Top Reviewer for American Journal of Preventive Medicine. Serves as Associate Editor for Frontiers in Nutrition. Active member of Cochrane Collaboration and multiple professional societies. Teaching: Graduate courses in Health Program Evaluation, Psychophysiology, and Systematic Review Design. Supervises doctoral students in health behavior research through 30+ dissertation committees since 2011. Labs/Teams: Key contributor to UAB's Nutrition Obesity Research Center (NORC) and Center for Outcomes and Effectiveness Research (COERE). Collaborates with international metadata initiatives like Metadata 2020 and science dialogue mapping projects.
Tania Fernández Villa is an Associate Professor in the Department of Biomedical Sciences at the Faculty of Veterinary Medicine, University of León. Her primary academic affiliation centers on preventive medicine and public health research within the GIIGAS (Interactions Gene-Environment-Health) research group. Her research spans nutritional epidemiology, gender studies in food systems, substance use disorders, and chronic disease prevention. Key focus areas include alcohol consumption patterns among university students (via the UniHcos cohort), sarcopenia in metabolic syndrome, breast cancer risk factors, and pandemic impacts on health behaviors. Her work integrates longitudinal cohort analysis, systematic reviews, and psychometric validation studies. Recent publications demonstrate strong trends in gender-disaggregated health research, pandemic-related behavioral shifts, and methodological innovations in dietary assessment. Her 2024-2025 output shows increasing emphasis on environmental sustainability of diets and multi-cancer risk prediction models. She serves on the editorial board of the Spanish Journal of Human Nutrition and Dietetics, contributing to strategic planning (2020-2026) and open science initiatives. Her PhD from Universidad de Granada focused on ICT usage patterns among university students. Current projects include the UniHcos longitudinal study tracking health behaviors in Spanish university students, with particular attention to alcohol use, sleep patterns, and nutritional status. Her research group actively investigates gene-environment interactions in public health contexts.
Zhandong Liu is an Associate Professor at Baylor College of Medicine with joint appointments in the Department of Pediatrics and Department of Neurology . He serves as Chief of Computational Sciences at Texas Children's Hospital and co-directs the Quantitative & Computational Biosciences Graduate Program at Baylor. Education: B.S. in Computer Science, Nankai University (2001) M.S. in Computer Science, Wayne State University (2003) Ph.D. in Genomics and Computational Biology, University of Pennsylvania (2010) Dr. Liu's research integrates genomics , machine learning , and bioinformatics to advance understanding of neurological diseases. His work focuses on: Multi-omics data integration for disease mechanism discovery Development of cloud-based CRISPR analysis tools like CRISPRcloud Augmented reality platforms for biomedical data visualization Identification of disease genes through computational models Alternative splicing analysis in cancer and neurodegeneration Single-cell and spatial transcriptomics algorithms His recent publications emphasize Alzheimer's disease , MECP2 syndromes , and computational therapy prediction across multiple domains. Scientific awards include the 2018 Outstanding Service Award from the International Association for Intelligent Biology and Medicine. He has secured major grants from NIH, CPRIT, and NSF for projects including: NSF grant #199977 (2018-2020): Augmented reality therapy platforms CPRIT grant #RP170387 (2016-2019): Network-guided cancer analysis NIH #1R01AG057339 (2017-2022): Alzheimer's disease networks As head of the Liu Lab , he leads teams developing tools like: MARRVEL : Human-model organism gene variant integration CRISPRcloud : Secure CRISPR screen analysis platform CrypSplice : Cryptic splicing detection algorithm
Eric Nauman is the Dane A. and Mary Louise Miller Professor of Biomedical Engineering at the University of Cincinnati and director of the Human Injury Research and Regenerative Technologies (H.I.R.R.T.) Lab. Previously, he held academic roles at Purdue University and Tulane University. He earned his Ph.D., M.S., and B.S. in Mechanical Engineering from UC Berkeley and the University of Delaware. Research Focus: The H.I.R.R.T. Lab investigates mechanisms of traumatic brain injury, spinal cord injury, musculoskeletal damage, atherosclerosis, and cancer metastasis. It develops protective and reconstructive treatments, including FDA-approved engineered tissue products for tendon repair. Collaborative projects emphasize translational research in injury prevention and treatment delivery. Grants & Awards: Lead Principal Investigator (PI) on federal grants totaling $4.7M for projects like AFRL teeming agreements and DoD biomathematical models. Recipient of prestigious awards including the Purdue Book of Great Teachers, Innovators Hall of Fame, and multiple teaching excellence recognitions. Key Contributions: Co-authored landmark TBI studies, holds 14 U.S. patents, and pioneered protective equipment innovations. His work bridges biomechanics, materials science, and clinical applications.
Dr. Yoshimi Fukuoka is a Professor at the University of California, San Francisco (UCSF) School of Nursing , specializing in Physiological Nursing . She holds a PhD in Nursing and Postdoctoral Fellowship from UCSF, with a career focused on AI-driven health interventions , chronic disease prevention , and mobile health (mHealth) applications for diverse populations. Her research bridges artificial intelligence and behavioral health , emphasizing personalized physical activity programs , cardiovascular risk reduction , and diabetes prevention . She has developed AI chatbots to improve heart disease awareness and conducted clinical trials on metabolic syndrome and colorectal cancer survivorship . Recent publications highlight her work on: AI chatbots for heart attack knowledge and physical activity interventions Machine learning in diabetes risk prediction and microRNA analysis Cultural adaptations of mHealth for Asian Americans and Latinos Behavioral analytics in weight loss and exercise adherence Scientific awards include: 2014-2017: National Science Foundation EAGER Grant 2011-2013: UCSF Diabetes Family Fund Award 2010-2012: American Heart Association National Clinical Research Program Award 2008: Marie Cowan Promising Young Investigator Award Her work spans UCSF , with collaborations across NIH , Alzheimer's Association , and Noyce Foundation , addressing health disparities , digital health policy , and precision health through grants like NIH R01HL104147 and K24NR015812 . Media coverage includes USA Today , NHLBI News , and UCSF News for her AI in nursing innovations.
Professor Tracy Bryan is a Professor in the Faculty of Medicine and Health at the University of Sydney and serves as Unit Head of the Cell Biology Unit at the Children's Medical Research Institute (CMRI). She holds a Bachelor of Science from Macquarie University and a PhD from the CMRI, where her groundbreaking research identified the ALT (Alternative Lengthening of Telomeres) mechanism in cancer cells. After postdoctoral work with Nobel Laureate Tom Cech at the University of Colorado, she returned to Australia in 2001 to establish her research group at CMRI. Her research focuses on telomerase biology, particularly its role in cancer progression and bone marrow failure syndromes. Key themes include understanding telomerase mechanisms, developing inhibitors for cancer therapy, and investigating telomere biology disorders. Her work integrates biochemical and cell-based approaches, supported by grants from NHMRC, Viertel Foundation, and Cancer Council NSW. Recent publications highlight advancements in telomerase-substrate interactions, i-motif DNA structures, and the interplay between telomere maintenance and DNA damage responses. Major grants include NHMRC Ideas Grants targeting telomere-related bone marrow failure and ARC Discovery Projects exploring DNA replication-telomere links. Bryan’s research group collaborates internationally, contributing to translational studies in oncology and regenerative medicine. Her lab’s work is detailed at CMRI’s Cell Biology Team page, with ongoing projects focused on telomerase inhibition strategies and molecular mechanisms of telomere dysfunction.
Rodrigo Fernandez Gonzalo is a Docent (Associate Professor) in Physiology and Principal Researcher at the Division of Clinical Physiology, Department of Laboratory Medicine, Karolinska Institutet. He leads the Space and Environmental Physiology research group focusing on skeletal muscle adaptation under various conditions including microgravity, aging, disease, and exercise. His research interests span skeletal muscle physiology, space physiology, and environmental physiology, with particular expertise in how skeletal muscle interacts with other physiological systems. His work employs diverse methodologies including human clinical studies, animal models, and cellular models to investigate functional, metabolic, morphological, molecular, and neural adaptations. Analysis of his recent publications reveals a strong focus on space physiology applications, particularly how microgravity affects skeletal muscle and immune systems, along with translational applications for clinical populations like those with cerebral palsy. His research integrates molecular analysis, imaging techniques, and physical performance outcomes to develop countermeasures for spaceflight effects. 4.5 MSEK funding from the Swedish National Space Agency (2020) Member of European Space Agency's Life Science Working Group (2022-2026) Member of Space Researchers Sweden (2021-) Dr. Fernandez Gonzalo serves as course responsible for Anatomy and Physiology in the nursing program (since 2018) and Advanced Human Physiology Research in the Master's programme in Translational Physiology and Pharmacology (since 2023). He also teaches Human Spaceflight at KTH and participates in the Erasmus Mundus Joint Master in Physiology and Medicine of Humans in Space and Extreme Environments. His laboratory utilizes facilities at Karolinska University Hospital and ANA Futura for human, animal, and cellular studies investigating space exposome effects.
Gustavo Alberto Nader is a Professor of Kinesiology at The Pennsylvania State University , holding the Dorothy Foher and J. Lloyd Huck Chair in Molecular, Cellular and Integrative Physiology. His research focuses on skeletal muscle growth control , ribosome biogenesis , and transcriptional/epigenetic regulation in health and disease contexts. Affiliated with the Huck Institutes of the Life Sciences and College of Health and Human Development Principal Investigator on NIH-funded projects examining ribosomal control of muscle mass Research Interests span molecular mechanisms of muscle adaptation to exercise, cancer cachexia, chronic disease impacts on muscle, and cross-species Wnt signaling regulation by CO₂ levels. Key methodologies include human/animal/cell models, ribosomal analysis, and epigenetic profiling. Publication Trends show sustained focus on: Ribosome biogenesis in muscle hypertrophy (2012–2025) Cancer-induced muscle wasting mechanisms (2015–2024) CO₂/Wnt pathway interactions (2015–2019) Exercise-induced transcriptional responses (2001–2016) Scientific Awards include the Huck Chair, while his Grants & Collaborations involve NIH-funded studies on transcriptional/epigenetic mechanisms (2019–2026) with cross-disciplinary teams in physiology, oncology, and respiratory medicine.
Dirk Repsilber is a Professor of Medical Science at Örebro University, specializing in functional bioinformatics. He leads research on molecular patterns in patients to improve diagnosis and treatment. Born in Lübeck, Germany, he earned his PhD in ecological genetics from the University of Hamburg and held postdoctoral roles at institutions across Sweden and Germany. His work integrates bioinformatics, biostatistics, and clinical collaboration to address complex biological systems. Education: PhD in Ecological Genetics (University of Hamburg, 1999), postdoctoral training at Uppsala University and SLU, followed by roles at German institutions including Lübeck, Potsdam, Rostock, and Örebro. Research Interests: Molecular networks, biosignature development, systems biology approaches to genotype-phenotype mapping, and interdisciplinary collaborations in medicine, statistics, and computer science. Key Projects: BIO IBD (biomarker discovery in inflammatory bowel disease), Cell Painting for toxicity assessment, and systems-level immunomonitoring in pediatric oncology. Active in cross-disciplinary teams like the Center for Life Sciences Nutrition-Gut-Brain Interactions. Teaching & Supervision: Cross-disciplinary courses in bioinformatics, statistical counseling, and supervision of PhD students in diverse fields. Emphasizes problem-based learning and communication skills across disciplines.
Christopher Grainge is a Conjoint Associate Professor at the University of Newcastle's School of Medicine and Public Health, and a Staff Specialist in Respiratory and General Medicine at John Hunter Hospital. Previously, he served as a Consultant Physician and Senior Lecturer at the University of Southampton. His extensive clinical background includes service in the Royal Navy, specializing in diving and remote medicine, and deployments to Antarctica and Southern Iraq. Dr. Grainge maintains active research collaborations with institutions worldwide, focusing on respiratory medicine. Dr. Grainge completed his undergraduate training at Imperial College, University of London, with an intercalated BSc. He earned his PhD from the University of Southampton in 2011, with research published in the New England Journal of Medicine. His thesis examined the effect of repeated bronchoconstriction on airways in asthma. He also holds membership in the Royal College of Physicians and was awarded the Diploma in the Medical Care of Catastrophes, specializing in remote and refugee medicine. Dr. Grainge's research focuses on the role of mechanical forces in asthma pathophysiology, environmental dusts in lung disease development, and platelet antagonists' effects on allergen challenge. His work demonstrates that mechanical forces play a crucial role in determining long-term changes in human airways. He leads investigations into how environmental exposure to inhaled particles leads to conditions like constrictive bronchiolitis, and explores novel therapeutic pathways for asthma through platelet activation inhibition. His research has significant clinical implications for difficult asthma and interstitial lung disease management. Dr. Grainge's recent publications reflect strong trends in interstitial lung disease research, particularly idiopathic pulmonary fibrosis, and asthma mechanisms. His work increasingly incorporates advanced technologies like artificial intelligence for disease stratification and deep learning for predicting disease progression. Collaborative research with international teams examines biomarkers for disease progression and novel treatment approaches for fibrotic lung diseases, with a particular focus on quantitative CT analysis and patient-reported outcome measures. Leatherdale Prize for Clinical Teaching: Finalist (2013) Military and Civilian Health Partnership Awards Winner (2011) University of Southampton Translational Medicine Research Prize (2011) Michael Arthur Clinical Research Prize (2014) British Lung Foundation Travel Fellowship (2011) Gilbert Blane Medal (2010) Colt Foundation Prize: Finalist (2010) Asthma UK Travel Fellowship (2009) Dr. Grainge has received significant research funding from the British Lung Foundation, the Southampton Marine and Maritime Institute, the Institute for Life Sciences, and the Gerald Kerkut Foundation. His projects investigate the effects of physical and environmental stress on lung disease, mechanisms underlying lung disease development following environmental particle exposure, and potential therapies. He has collaborated extensively with research teams across Australia, the UK, the Netherlands, and South Africa, contributing to the training of numerous students and junior researchers through his supervision and mentorship roles. Dr. Grainge collaborates extensively with the Respiratory Research group at the University of Southampton, the Asthma and COPD Research Group at the University of Groningen in the Netherlands, and the Microbiome group at the South Australia Medical Research Institute. His current work at the Hunter Medical Research Institute (HMRI) focuses on mechanical forces within airways and their impact on acute and long-term lung changes in patients with airway diseases. He is also involved in the Australian IPF Registry, contributing to multicenter studies on idiopathic pulmonary fibrosis progression and treatment outcomes.
Emanuel Petricoin is a Professor and Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University's School of Systems Biology, a position held since 2005 with prior leadership at the FDA-NCI Clinical Proteomics Program (1993-2005). His academic affiliation spans proteomics, molecular medicine, and precision oncology within GMU's research ecosystem. His educational background includes: Ph.D. in Microbiology from the University of Maryland, College Park (1990) Dr. Petricoin pioneers clinical proteomics for personalized therapy and biomarker discovery, with seminal work in cancer signaling pathways, tumor microenvironment analysis, and diagnostic assay development. His research integrates proteogenomics, phosphoproteomics, and functional protein analysis to address therapeutic resistance in breast and pancreatic cancers. As a translational scientist, he bridges laboratory innovation with clinical implementation through FDA-regulated platforms. Analysis of his 2024-2025 publications reveals dominant themes in proteogenomic tumor characterization, KRAS/HER2 pathway dynamics, and biomarker-guided immunotherapy. Key trends include spatial proteomics of tumor heterogeneity, extracellular vesicle-mediated signaling, and quantitative assessment of drug targets for precision oncology decision-making. The work consistently emphasizes clinical applicability through CLIA-certified assays and molecular tumor boards. His scientific recognition includes: University Professorship at George Mason University NIH Director’s Award FDA Distinguished Scientist Award 2015 Innovator of the Year Award GAP50 Top Virginia Entrepreneurs Nifty 50 Award American Society of Cytopathology Basic Research Award Roche Diagnostics/CLAS Distinguished Scientist Award Harvard University Leading Edge Award Dr. Petricoin drives research commercialization as co-founder of four biotech firms (Theranostics Health, Ceres Nanosciences, C-4 Diagnostics, Perthera) and co-inventor of 40+ patents. His editorial leadership spans Proteomics, Cancer Epidemiology Biomarkers and Prevention, and other high-impact journals. He actively shapes national initiatives as a HUPO founding member and Virginia Health Research Biosciences Corporation board representative. The CAPMM under his co-direction serves as a national hub for clinical proteomics, specializing in reverse-phase protein array (RPPA) technology, laser capture microdissection, and biomarker validation for direct patient care applications. The center integrates multi-omic data to advance personalized cancer therapy through industry partnerships and clinical trial support.
Dr. Jessica Grieger is a Research Fellow at the University of Adelaide, affiliated with the Adelaide Medical School under the Faculty of Health and Medical Sciences. Her research focuses on maternal diet, metabolic health, and reproductive outcomes, with a particular emphasis on gestational diabetes, fertility, and developmental origins of disease. Her research program includes systematic reviews and meta-analyses on gestational diabetes prevention, intervention components, and the impact of preconception diet on fertility. She has contributed to high-impact studies in journals like Communications Medicine and Human Reproduction Update . Dr. Grieger's scientific work has been recognized through her NHMRC Externally-Funded Research Fellow position, and her findings have informed clinical guidelines and public health strategies. She supervises honors and higher degree research students in dietary analysis, qualitative methods, and metabolic syndrome studies. Her collaborations span institutions like the Australian Pathogen Genomics Program and involve developing genomic tools for pathogen tracking. She also explores telomere biology in offspring and the implementation of precision medicine approaches for maternal health.
